Literature DB >> 8345209

Pentoxifylline attenuates neutrophil activation in experimental endotoxemia in chimpanzees.

D van Leenen1, T van der Poll, M Levi, H ten Cate, S J van Deventer, C E Hack, L A Aarden, J W ten Cate.   

Abstract

Costimulation of neutrophils and cytokines may play an important role in organ injury in sepsis. Pentoxifylline inhibits various neutrophil functions in vitro, and attenuates endotoxin-induced production of TNF in both in vitro and in vivo models. To assess the effect of pentoxifylline on neutrophil activation in endotoxemia, nine adult chimpanzees (Pan troglodytes) were i.v. injected with saline (n = 2), Escherichia coli endotoxin (4 ng/kg; n = 4), or E. coli endotoxin (4 ng/kg) in combination with pentoxifylline (500 mg/3 h, starting 30 min before the endotoxin injection; n = 3). Serial blood samples were obtained for measurements of leukocyte counts and the granulocytic proteinases elastase complexed with alpha 1-antitrypsin and lactoferrin, and cytokines during the next 5 h. No changes were observed in the saline-treated chimpanzees. Endotoxin induced a marked leukocytosis and neutrophilia, which were slightly reduced by pentoxifylline. In contrast, pentoxifylline almost completely prevented endotoxin-induced neutrophil degranulation: peak elastase-alpha 1-antitrypsin was 164 +/- 21 ng/ml (mean +/- SE) after endotoxin alone, vs 71 +/- 7 ng/ml after endotoxin with pentoxifylline (t = 3 h; p < 0.05); peak lactoferrin was 329 +/- 15 and 182 +/- 5 ng/ml, respectively (t = 5 h; p < 0.05). Pentoxifylline also inhibited the endotoxin-induced release of TNF (271 +/- 26 vs 55 +/- 23 pg/ml at t = 1.5 h; p < 0.05) and IL-6 (225 +/- 42 vs 73 +/- 25 pg/ml at t = 2 h; p < 0.05). IL-8 release was not significantly inhibited by pentoxifylline. In none of the animals activation of the C system could be detected. We conclude that pentoxifylline attenuates neutrophil activation in endotoxemia in chimpanzees, probably in part by inhibiting the release of TNF.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8345209

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Activation of mononuclear cells by interleukin-12: an in vivo study in chimpanzees.

Authors:  F N Lauw; A A te Velde; P E Dekkers; P Speelman; J M Aerts; C E Hack; S J van Deventer; T van der Poll
Journal:  J Clin Immunol       Date:  1999-07       Impact factor: 8.317

Review 2.  Small therapeutic molecules for the treatment of inflammatory bowel disease.

Authors:  S J H van Deventer
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

3.  Studies of skin-window exudate human neutrophils: increased resistance to pentoxifylline of the respiratory burst in primed cells.

Authors:  A Carletto; D Biasi; L M Bambara; P Caramaschi; M L Bonazzi; S Lussignoli; G Andrioli; P Bellavite
Journal:  Inflammation       Date:  1997-04       Impact factor: 4.092

4.  Treatment with tumour necrosis factor inhibitor oxpentifylline does not improve corticosteroid dependent chronic active Crohn's disease.

Authors:  J Bauditz; J Haemling; M Ortner; H Lochs; A Raedler; S Schreiber
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

5.  Pentoxifylline attenuates ischemia/reperfusion injury to the small intestine in the rat.

Authors:  R Udassin; A Vromen; D Seror; Y Haskel
Journal:  Pediatr Surg Int       Date:  2013-09-21       Impact factor: 1.827

6.  Inhibition of the release of soluble tumor necrosis factor receptors in experimental endotoxemia by an anti-tumor necrosis factor-alpha antibody.

Authors:  J Jansen; T van der Poll; M Levi; H ten Cate; H Gallati; J W ten Cate; S J van Deventer
Journal:  J Clin Immunol       Date:  1995-01       Impact factor: 8.317

7.  Pentoxifylline reduces plasma tumour necrosis factor-alpha concentration in premature infants with sepsis.

Authors:  R Lauterbach; M Zembala
Journal:  Eur J Pediatr       Date:  1996-05       Impact factor: 3.183

8.  Pentoxifylline influences the autocrine function of organ cultured donor corneas and enhances endothelial cell survival.

Authors:  A C Ventura; M Böhnke
Journal:  Br J Ophthalmol       Date:  2001-09       Impact factor: 4.638

9.  Protection from endotoxic shock in mice by pharmacologic inhibition of phosphatidic acid.

Authors:  G C Rice; P A Brown; R J Nelson; J A Bianco; J W Singer; S Bursten
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

10.  Pattern of cytokines and pharmacomodulation in sepsis induced by cecal ligation and puncture compared with that induced by endotoxin.

Authors:  P Villa; G Sartor; M Angelini; M Sironi; M Conni; P Gnocchi; A M Isetta; G Grau; W Buurman; L J van Tits
Journal:  Clin Diagn Lab Immunol       Date:  1995-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.